140 related articles for article (PubMed ID: 38476972)
1. High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda.
Ssenkumba B; Atwiine B; Mitala Y; Adongo J; Olowo S; Nabulya R; Diaz Anaya A; Atwine R
Cancer Manag Res; 2024; 16():127-136. PubMed ID: 38476972
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis.
Morgan ED; Yahaya JJ; Ngaiza AI; Othieno E; Livex OA
J Egypt Natl Canc Inst; 2023 Jul; 35(1):23. PubMed ID: 37518096
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
4. The significance of Wilms Tumor Gene (WT1) and p53 expression in curettage specimens of patients with endometrial carcinomas.
Matalka I; Obeidat B; Mohtaseb A; Awamleh A
Pathol Res Pract; 2013 Jan; 209(1):19-23. PubMed ID: 23207289
[TBL] [Abstract][Full Text] [Related]
5. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53.
Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR
J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
7. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
8. Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary.
Makrigiannakis A; Amin K; Coukos G; Tilly JL; Coutifaris C
J Clin Endocrinol Metab; 2000 Jan; 85(1):449-59. PubMed ID: 10634423
[TBL] [Abstract][Full Text] [Related]
9. Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.
Cedrés S; Montero MA; Zamora E; Martínez A; Martínez P; Fariñas L; Navarro A; Torrejon D; Gabaldon A; Ramon Y Cajal S; Felip E
Clin Transl Oncol; 2014 Sep; 16(9):776-82. PubMed ID: 24323466
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.
Karamurzin Y; Leitao MM; Soslow RA
Am J Surg Pathol; 2013 Mar; 37(3):356-67. PubMed ID: 23282975
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in Wilms' tumor: a possible role as prognostic factor.
Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
[TBL] [Abstract][Full Text] [Related]
12. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
13. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
14. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.
Murphy AJ; Axt JR; de Caestecker C; Pierce J; Correa H; Seeley EH; Caprioli RM; Newton MW; de Caestecker MP; Lovvorn HN
Int J Cancer; 2012 Sep; 131(6):E983-94. PubMed ID: 22437966
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Ki67 and p53 in Wilms Tumor and Its Relationship with Tumor Histology and Stage at Presentation.
Krishna OH; Kayla G; Abdul Aleem M; Malleboyina R; Reddy Kota R
Patholog Res Int; 2016; 2016():6123951. PubMed ID: 26904359
[TBL] [Abstract][Full Text] [Related]
17. A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy.
Casey L; Köbel M; Ganesan R; Tam S; Prasad R; Böhm S; Lockley M; Jeyarajah AJ; Brockbank E; Faruqi A; Gilks CB; Singh N
Histopathology; 2017 Nov; 71(5):736-742. PubMed ID: 28570008
[TBL] [Abstract][Full Text] [Related]
18. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study.
Charles AK; Mall S; Watson J; Berry PJ
Mol Pathol; 1997 Jun; 50(3):138-44. PubMed ID: 9292148
[TBL] [Abstract][Full Text] [Related]
20. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
